Amgen to Present at the Goldman Sachs Global Healthcare Conference
June 08 2009 - 5:34PM
PR Newswire (US)
THOUSAND OAKS, Calif., June 8 /PRNewswire-FirstCall/ -- Amgen
(NASDAQ: AMGN) will present at the Goldman Sachs Global Healthcare
Conference on Wednesday, June 10, 2009 at the Grand Hyatt, New York
City, N.Y., beginning at 9:00 a.m. Eastern Time. Roger M.
Perlmutter, Amgen's Executive Vice President of Research &
Development, will present. Live audio of the presentation will be
available over the Internet and can be accessed from Amgen's Web
site, http://www.amgen.com/, under Investors. Information regarding
presentation time, webcast availability, and webcast links are
available on Amgen's Investor Relations Events Calendar. About
Amgen Amgen discovers, develops, manufactures and delivers
innovative human therapeutics. A biotechnology pioneer since 1980,
Amgen was one of the first companies to realize the new science's
promise by bringing safe and effective medicines from lab, to
manufacturing plant, to patient. Amgen therapeutics have changed
the practice of medicine, helping millions of people around the
world in the fight against cancer, kidney disease, rheumatoid
arthritis, and other serious illnesses. With a deep and broad
pipeline of potential new medicines, Amgen remains committed to
advancing science to dramatically improve people's lives. To learn
more about our pioneering science and our vital medicines, visit
http://www.amgen.com/. CONTACT: Amgen, Thousand Oaks David Polk,
805-447-4613 (media) John Shutter, 805-447-1060 (investors) (Logo:
http://www.newscom.com/cgi-bin/prnh/20081015/AMGENLOGO)
http://www.newscom.com/cgi-bin/prnh/20081015/AMGENLOGO
http://photoarchive.ap.org/ DATASOURCE: Amgen CONTACT: media, David
Polk, +1-805-447-4613, or investors, John Shutter, +1-805-447-1060,
both of Amgen, Thousand Oaks Web Site: http://www.amgen.com/
Copyright